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Abstract
Background—The differentiation of TH17 cells, which promote pulmonary inflammation, 
requires the cooperation of a network of transcription factors.
Objectives—We sought to define the role of Etv5, an Ets-family transcription factor, in TH17 
cell development and function.
Methods—TH17 development was examined in primary mouse T cells wherein Etv5 expression 
was altered by retroviral transduction, small interfering RNA targeting a specific gene, and mice 
with a conditional deletion of Etv5 in T cells. The direct function of Etv5 on the Il17 locus was 
tested with chromatin immunoprecipitation and reporter assays. The house dust mite–induced 
allergic inflammation model was used to test the requirement for Etv5-dependent TH17 functions 
in vivo.
Results—We identify Etv5 as a signal transducer and activator of transcription 3–induced 
positive regulator of TH17 development. Etv5 controls TH17 differentiation by directly promoting 
0a and Il17f expression. Etv5 recruits histone-modifying enzymes to the Il17a–Il17f locus, 
resulting in increased active histone marks and decreased repressive histone marks. In a model of 
allergic airway inflammation, mice with Etv5-deficient T cells have reduced airway inflammation 
and IL-17A/F production in the lung and bronchoalveolar lavage fluid compared with wild-type 
mice, without changes in TH2 cytokine production.
Conclusions—These data define signal transducer and activator of transcription 3–dependent 
feed-forward control of TH17 cytokine production and a novel role for Etv5 in promoting T cell–
dependent airway inflammation.
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Helper T cells play an essential role in adaptive immunity, with specific subsets contributing 
effector functions to control immunity to pathogens and regulating the development of 
inflammatory disease. Specific cytokines in the microenvironment mediate intracellular 
communication that results in the activation of signal transducer and activator of 
transcription (STAT) proteins and the induction of a transcriptional regulatory network. 
IL-6, IL-21, or IL-23 can activate STAT3, which is required for TH17 cell differentiation 
and maintenance.1,2 TH17 cells secrete IL-17A, IL-17F, IL-21, and IL-22 and are primary 
mediators in controlling infection and promoting autoimmune diseases.3’4 ΓL-17–producing 
CD4+ T cells have been shown to be required for immunity to Candida albicans, 
Mycobacterium tuberculosis, Streptococcus pneumonia, and Klebsiella pneumoniae.5–8 
TH17 cells also play a key role in the development of autoimmune inflammation, including 
experimental autoimmune encephalomyelitis, rheumatoid arthritis, and inflammatory bowel 
disease.9–11 STAT3 activation by IL-6, IL-21, and IL-23 results in the induction of genes 
encoding transcription factors, including Rorc, Maf, Irf4, and Batf, which are essential for 
TH17 cell differentiation.12–16 Although each of these factors are critical for TH17 cell 
development, 17,18 it is not clear whether additional STAT3 targets are required for TH17 
cell development and function.
ETS variant 5 (Etv5) belongs to the PEA3 subfamily of ETS transcription factors that 
regulate gene expression by binding to a conserved GGAA/T motif.19 Etv5 has been shown 
to play important roles in coordinating limb development,20,21 controlling gene expression 
in spermatogonial stem cells22, and regulating epithelial-mesenchymal transition in many 
type of cancers.19 Etv5 inhibits sonic hedgehog expression in the anterior limb bud, which is 
essential for the anterior-posterior patterning of the vertebrate limb21. Etv5 positively 
regulates microRNA-21, Bcl6b, and LIM homeobox 1, which are known to control 
spermatogonial stem cell self-renewal.23 Chromosomal translocations resulting from the 
fusion between Etv5 and trans-membrane protease serine 2 correlate with prostate cancer.19
Although the role of Etv5 in developmental and cancer biology has been defined, the 
function of Etv5 in the immune response is still poorly understood. One report found Etv5 
downstream of the IL-12–STAT4 signaling pathway, augmenting IFN-γ production in TH1 
cells.24,25 The role of Etv5 in the development of other helper T cells has not been defined. 
In this report we show that STAT3-activating cytokines induce Etv5 expression in TH17 
cells. Etv5 promotes IL-17 production in TH17 cells in vitro and in vivo and is required in T 
cells for the development of allergic inflammation. Mechanistically, Etv5 directly promotes 
Il17a and Il17f expression. Thus Etv5 is a STAT3-induced positive regulator of TH17 cell 
differentiation, promoting the development of allergen-induced airway inflammation.
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METHODS
Mice
C57BL/6 mice were purchased from Harlan Sprague Dawley (Indianapolis, Ind). Stat3fl/fl 
CD4-Cre mice were previously described.26 Etv5fl/fl mice21 were crossed withCD4-Cre 
transgenic mice to generate Etv5 fl/fl CD4-Cre+ mice, with Cre-negative littermates as 
control mice. Mice were maintained under specific pathogen-free conditions. All 
experiments were performed with the approval of the Indiana University Institutional 
Animal Care and Use Committee.
In vitro T-cell differentiation
Naive CD4+CD62L+T cells were positively selected from enriched CD4+ T cells from 
spleens and lymph nodes by using MACS beads and columns (Miltenyi Biotec, Auburn, 
Calif). Naive CD4+CD62L+T cells were activated with plate-bound anti-CD3 (2 µg/mL 
145-2C11; Bio-XCell, West Lebanon, NH) and soluble anti-CD28 (0.5 µg/mL; BD 
PharMingen, San Jose, Calif) to generate TH0 cells or with additional cytokines (all from 
PeproTech, Rocky Hill, NJ) and antibodies (Bio-XCell) to generate TH1 (5 ng/mL IL-12 and 
10 µg/mL anti–IL-4, 11B11), TH2 (10 ng/mL IL-4 and 10 µg/mL anti–IFN-γ, XMG), TH9 
(20 ng/mL IL-4, 2 ng/mL TGF-β, and 10 µg/mL anti–IFN-γ; XMG), TH17 (100 ng/mL IL-6, 
10 ng/mL IL-23, 10 ng/mL IL-1β, 2 ng/mL TGF-β, and 10 µg/mL anti–IL-4, 11B11, and 10 
µg/mL anti–IFN-γ, XMG), or inducible regulatory T (iTreg; 2 ng/mL TGF-β and 10 µg/mL 
anti–IL-4, 11B11) cells in culture conditions. Cells were expanded after 3 days with a half 
concentration of the original cytokines in fresh medium. Cells were harvested on day 5 for 
analysis.
House dust mice–induced allergic airway inflammation
Wild-type and Etv5 mutant mice were sensitized by means of intranasal injection of 40 µg of 
house dust mite (HDM; Greer Laboratories, Lenoir, NC) in PBS each day for 3 consecutive 
days over 5 weeks. In experiments as indicated, mice were treated with 200 µg of anti–
IL-17A (17F3) or IgG1 (MOPC-21) antibodies (Bio-XCell) for 3 consecutive days over 5 
weeks or 4 µg of IL-17A/F cytokine (PeproTech) on weeks 3, 4, and 5. Mice were killed 24 
hours after the final intranasal challenge at week 5. The trachea was cannulated, and lungs 
were lavaged 3 times with 1 mL of PBS to collect bronchoalveolar lavage (BAL) cells. BAL 
cells and the single-cell suspension from lungs generated by using the lung dissociation kit 
from Miltenyi Biotec were stimulated with phorbol 12-myristate 13-acetate (PMA) and 
ionomycin for 2 hours followed by monensin for a total of 6 hours for cytokine analysis by 
means of intracellular staining. Single-cell suspension from the lungs was used for gene 
expression analysis with quantitative reverse transcriptase PCR (qRT-PCR). Cells from 
mediastinal lymph nodes were stimulated with HDM for 5 days, and cytokine production 
was analyzed by using ELISA. Lung tissue was analyzed after paraffin embedding and 
staining with hematoxylin and eosin for evaluation of the infiltration of inflammatory cells, 
and periodic acid–Schiff was used for evaluation of mucus production. Eosinophils, 
neutrophils, T cells, B cells, and mononuclear cells in the BAL fluid and lungs were 
characterized by cell size and expression of CD3, B220, CCR3, CD11c, and MHC class II 
by using flow cytometric analysis, as described previously.27
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Retroviral expression vectors and retroviral transduction
Etv5 (Open Biosystems, Thermo Scientific, Waltham, Mass) cDNA was digested and 
subcloned into MSCV-YFP. Bicistronic retrovirus expressing YFP preparation of retroviral 
stocks was previously described.28 CD4+ T cells were transduced on day 2 with control or 
retrovirus vector expressing the gene of interest by using centrifugation at 2000 rpm at 25°C 
for 1 hour in the presence of 8 µg/mL polybrene (Sigma-Aldrich, St Louis, Mo). Viral 
supernatant was replaced with the former culture supernatant supplemented with 50 U/mL 
human IL-2. After spin infection, cells were expanded on day 3 and analyzed on day 5.
Transfection of small interfering RNA
Control small interfering RNA (siRNA) and siRNA targeting Etv5 were purchased from 
Santa Cruz Biotechnology (Santa Cruz, Calif). TH17 cells were transfected with control or 
Etv5 siRNA on day 2 with the Amaxa Nucleofector kit (Lonza, Basel, Switzerland), rested 
overnight with human IL-2, and restimulated with anti-CD3 for 24 hours for gene 
expression and cytokine production analysis.
Luciferase reporter assay
Jurkat T cells were grown in RPMI-1640 with 10% FBS and transfected with 2 to 5 µg of 
the IL17A/F luciferase reporter plasmids (SwitchGear Genomics, Menlo Park, Calif) and 
control or increasing concentration of plasmid expressing Etv5 through Fugene6 reagent 
(Roche, Mannheim, Germany). After 24 hours, transfected cells were stimulated with PMA 
and ionomycin for 6 hours before analysis with the dual luciferase system (Promega, 
Madison, Wis).
Analysis of gene expression, protein expression, ELISA, and flow cytometry
qRT-PCR and ELISA were performed, as previously described.29 Gene expression was 
normalized to housekeeping gene (β2-microglobulin) expression. The relative gene 
expression was calculated by using the change-in-threshold (−ΔΔCT) method. Primers are 
listed in Table E2 in this article’s Online Repository at www.jacionline.org. Nuclear lysates 
were extracted from activated CD4+ T cells and immunoblotted with Etv5 C-20 or β-Actin 
C4 (Santa Cruz Biotechnology) as a control. For flow cytometry, cells were stained for 
surface markers and fixed with 2% paraformaldehyde for 10 minutes before analysis. For 
cytokine staining, CD4+ T cells were stimulated with PMA and ionomycin for 2 hours 
followed by monesin for a total of 6 hours, fixed, permeabilized with 0.2% saponin, and 
stained for IL-17A–PECy7, IL-17F–phycoerythrin, or IL-13– Alexa Fluor 647 (BD 
PharMingen). For Etv5 intracellular staining, cells were fixed, permeabilized with 0.1% 
saponin, and stained for Etv5 C-20 or goat IgG (Santa Cruz Biotechnology) for 30 minutes 
at 4°C, followed by donkey anti-goat IgG PE (Santa Cruz Biotechnology) for an additional 
30 minutes at 4°C.
Chromatin immunoprecipitation
The chromatin immunoprecipitation (ChIP) assay was performed, as previously described.24 
In brief, resting TH17 cells were cross-linked for 10 minutes with 1% formaldehyde and 
lysed by means of sonication. After preclearing with salmon sperm DNA, BSA, and Protein 
Pham et al. Page 4
J Allergy Clin Immunol. Author manuscript; available in PMC 2015 July 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Agarose bead slurry (50%), cell extracts were incubated with either rabbit polyclonal 
STAT3 C-20, Etv5 H-100, p300 N-15 (Santa Cruz Biotechnology), H3K27ac, H3K27me3 
(Milli-pore, Temecula, Calif), H3K4me3 (Abcam, Cambridge, United Kingdom), or normal 
rabbit IgG (Millipore) overnight at 4°C. The immunocomplexes were precipitated with 
protein Agarose beads at 4°C for 2 hours, washed, and eluted, and cross-links were reversed 
at 65°C overnight. DNA was purified, resuspended in H2O, and analyzed by using 
quantitative PCR. Primers are listed in Table E1 in this article’s Online Repository at 
www.jacionline.org. The percentage input was calculated by subtracting the amount of 
immunoprecipitated DNA from the IgG control from the amount of immunoprecipitated 
DNA from the specific antibody and normalized against the amount of input DNA.
Statistical analysis
A 2-tailed Student t test or 1-way ANOVA was used to generate P values for all data, with a 
P value of .05 or less considered significant.
RESULTS
Etv5-deficient T cells display defects in helper T-cell differentiation
Although evidence suggests that Etv5 contributes modestly to IFN-γ production in TH1 
cells,25 the role of Etv5 in helper T-cell development is still poorly understood. To define 
the function of Etv5 in T cells, we generated mice with Etv5 deficiency in T cells (Etv5fl/fl 
CD4-Cre+) by mating Etv5fl/fl mice21 with mice carrying a CD4-Cre transgene (termed Etv5 
mutant mice) and confirmed the absence of Etv5 expression in Etv5-deficient T cells (Fig 1, 
A). Mice with Etv5-deficient T cells display T-cell populations in the thymus, spleen, and 
lymph nodes comparable with those seen in wild-type littermate control animals and showed 
normal proliferation in culture (Fig 1, B and C, and data not shown). To define the role of 
Etv5 in helper T-cell differentiation, we first examined Etv5 expression in helper T-cell 
subsets. Etv5 expression was highest in resting and activated TH1 and TH2 cells compared 
with other helper cell subsets at the message and protein levels (Fig 2, A-C). Naive CD4+ T 
cells from control and Etv5 mutant mice were used to generate TH1, TH2, and TH17 
cultures, and cytokine production and gene expression were assessed. Interestingly, there 
were multiple defects in helper T-cell differentiation. Etv5-deficient TH2 cells produced 
more IL-4. In contrast, Etv5-deficient TH17 cells produced significantly less IL-17A 
compared with control cells (Fig 2, D). Similar results were observed at the message level in 
Etv5-deficient T cells compared with control cells (Fig 2, E). IFN-γ production was 
modestly increased in Etv5-deficient TH1 cells compared with that seen in wild-type cells 
(Fig 2, D and E). Examination of transcription factor expression critical for the development 
of each effector subset demonstrated that expression of Gata3 and Rorc was similar between 
control and Etv5-deficient TH2 and TH17 cells, respectively (Fig 2, F). Etv5-deficient TH1 
cells had higher Tbx21 expression compared with that seen in control cells (Fig 2, F). 
Numbers of thymic-derived regulatory T (Treg) cells (defined as CD4+CD25+ forkhead box 
protein 3 [Foxp3]+ cells) in both lymph nodes and spleen and in vitro–derived Treg cells 
(iTreg cells) were not significantly decreased in Etv5-mutant mice compared with control 
mice (data not shown). Thus mice that lack Etv5 expression in T cells display altered helper 
T-cell differentiation in vitro.
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Mice with Etv5-deficient T cells had reduced allergic inflammation
Our data suggested that Etv5 plays a repressive role in TH1 and TH2 cell differentiation 
while promoting TH17 cell differentiation (Fig 2). HDM-induced allergic airway 
inflammation is TH2 and TH17 dependent,30–33 and in exploring Etv5-dependent immunity, 
we first wanted to confirm the role of IL-17A in this model. We sensitized and challenged 
mice with intranasal HDM antigen and anti–IL-17A or IgG1 antibodies for 5 weeks and 
assessed pulmonary inflammation (Fig 3, A). Mice treated with anti–IL-17A antibody had 
significantly lower numbers of total cells, eosinophils, and neutrophils in lung tissue and 
BAL fluid compared with control mice (Fig 3, B). Consistent with the decrease in neutrophil 
numbers, expression of Cxcl2, an IL-17– induced gene, but not Cxcl1, was reduced in lung 
tissue from mice treated with anti–IL-17A antibody compared with control lung tissue (Fig 
3, C). Our results demonstrated that IL-17A is important in mediating allergic airway 
inflammation on HDM allergen exposure.
We next wanted to test the role of Etv5 in vivo by inducing allergic airway inflammation in 
control and Etv5 mutant mice. Etv5 mutant mice had significantly decreased numbers of 
total cells and specific cell populations in lung tissue compared with control mice (Fig 3, D). 
Analysis of the cellular composition after BAL showed similar results (Fig 3, E). Histologic 
examination also demonstrated diminished inflammatory cell infiltrates in the lungs and 
decreased mucus production in the airways of Etv5 mutant mice compared with control mice 
(Fig 3, F). Consistent with histologic analysis, the expression of genes involved in goblet 
cell metaplasia (Muc5ac and Clca3) was reduced in lungs of Etv5 mutant mice compared 
with that seen in control mice (Fig 3, G). Given that we observed the greatest fold reduction 
(>5-fold) in infiltrating neutrophils in Etv5 mutant mice compared with control mice (Fig 3, 
D and E), we wanted to examine the expression of neutrophil-attractant chemokines in total 
lung RNA. Consistent with the decrease in neutrophil numbers, expression of Cxcl2, an 
IL-17–induced gene, was reduced in lung tissue from Etv5 mutant mice compared with that 
seen in control lung tissue (Fig 3, G). In contrast, there was no difference in Cxcl1 
expression or in expression of the TH2-induced chemokines Ccl17 and Ccl22 (Fig 3, G).
We next assessed cytokine production in the lung tissue and BAL fluid of control and Etv5 
mutant mice with HDM-induced allergic inflammation. Consistent with in vitro analyses, 
there was a significantly decreased frequency and number of IL-17A–producing CD4+ T 
cells from the lung and BAL cells of Etv5 mutant mice compared with that seen in control 
mice (Fig 4, A-C, and data not shown). No change was observed in the frequency of IL-13–
producing CD4+ T cells from the lung and BAL cells, although cell numbers were decreased 
in Etv5 mutant mice compared with those seen in control mice, which is concomitant with 
the decrease in overall inflammation in the lung (Fig 4, A-C). We further confirmed that the 
concentration of IL-17A, but not IL-13 and IL-4, was significantly reduced in the BAL fluid 
of Etv5 mutant mice compared with that seen in control mice (Fig 4, D). The frequencies of 
Treg cells (identified as CD4+ Foxp3+ ) in the lung and BAL cells were similar between 
control and Etv5 mutant mice (data not shown). We next assessed the generation of helper 
T-cell responses in the periphery by stimulating mediastinal lymph node cells with HDM 
extract. IL-17A production was significantly reduced in Etv5 mutant mice compared with 
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that seen in control mice, although there was no difference in the amount of IL-13 or IL-4 
(Fig 4, E).
To determine whether loss of IL-17 is the critical defect in Etv5 mutant mice, we treated 
HDM-sensitized Etv5 mutant mice with either PBS or IL-17A and IL-17F together and 
assessed pulmonary inflammation (Fig 5, A). IL-17A/F–treated Etv5 mutant mice had 
increased numbers total cell, eosinophil, and neutrophil numbers in lung tissue and BAL 
fluid compared with those seen in the PBS group (Fig 5, B). In addition, Cxcl2, but not 
Cxcl1, gene expression was increased when Etv5 mutant mice were treated with IL-17A/F 
cytokines compared with values seen in control mice (Fig 5, C). Collectively, these results 
suggested that the critical role of Etv5 in vivo in response to an allergen in experimental 
airway inflammation is the regulation of IL-17–secreting T cells.
STAT3-activating cytokines induce Etv5 expression
Given that Etv5 positively regulates IL-17A in vitro and in HDM-induced allergic 
inflammation, we wanted to further elucidate the ability of Etv5 to promote TH17 cell 
differentiation. We first assessed the kinetics of Etv5 gene expression during TH17 cell 
differentiation. We observed an increase in Etv5 expression 48 hours after activation that 
gradually decreased over the subsequent 3 days of differentiation (Fig 6, A). Because 
STAT4 regulates Etv5 expression in TH1 cells,25 we tested whether STAT3 induced Etv5 
expression in TH17 cultures. Stimulation of wild-type TH17 cells with IL-6 or IL-23 to 
activate STAT3 or IL-12 to activate STAT4 led to increased Etv5 mRNA and protein 
expression compared with that seen in unstimulated cells (Fig 6, B and C). To further 
confirm that Etv5 is a STAT3 target gene, we treated activated control and Stat3-deficient T 
cells with or without IL-6 for 48 hours to induce receptor expression. Cells were harvested, 
rested overnight, and restimulated with IL-6, IL-12, or IL-23 to assess Etv5 expression. As 
expected, IL-6, IL-23, or IL-12 induced Etv5 expression in IL-6–primed CD4+ T cells (Fig 
6, D). However, IL-6– and IL-23–induced, but not IL-12–induced, expression of Etv5 was 
STAT3 dependent (Fig 6, D). To determine whether STAT3 could directly bind to 
conserved STAT-binding sites (consensus STAT3-binding sequence TTN4–5AA34) in the 
mouse and human Etv5 genes (Fig 6, E), differentiated wild-type TH17 cells were stimulated 
with STAT3-activating cytokines, and binding was examined using ChIP assay. In TH17 
cells STAT3-activating cytokines, but not IL-12, resulted in STAT3 binding to the Etv5 
promoter, with greater amounts at the distal than the proximal binding sites (Fig 6, F). The 
decreased STAT3 binding after IL-12 stimulation is likely due to displacement by STAT4 
(Fig 6, F). These results suggested that STAT3-activating cytokines, including IL-6 and 
IL-23, promote Etv5 expression in TH17 cells.
Etv5 directly activates the Il17a-Il17f locus in TH17 cells
To further define the function of Etv5 in TH17 cell programming, we ectopically expressed 
Etv5 in TH17 cells and assessed cytokine production. Ectopic Etv5 expression in TH17 cells 
resulted in increased IL-17A and IL-17F production compared with that seen in control cells 
(Fig 7, A and B). To test whether Etv5 alone could induce IL-17 production in CD4+ T cells, 
Etv5 was ectopically expressed in nonpolarized CD4+ T cells (TH0 cells). Ectopic Etv5 
expression in TH0 cells was able to induce IL-17A production compared with that seen in 
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control cells (Fig 7, C). Consistent with these observations, reduced Etv5 expression in 
TH17 cells by transfecting T cells with siRNA targeting Etv5 (Fig 7, D) or using Etv5-
deficient T cells (Fig 7, E) resulted in decreased IL-17A and IL-17F levels compared with 
those seen in control cells. IL-21 production was decreased in the absence of Etv5, but GM-
CSF and IL-10 production was not significantly different in control cells from that seen in 
cells that lack Etv5 expression (Fig 7, D and E). We next examined the expression of 
transcription factors that are required for TH17 cell differentiation.13,15,16,35,36 Surprisingly, 
reduced Etv5 expression did not alter gene expression of Rorc, Batf, Maf, and Irf4 (Fig 7, F 
and G). Because Etv5 did not affect any of the known regulators of IL-17A–IL-17F 
expression, we tested whether Etv5 directly regulated expression of the Il17a-Il17f locus. 
The ChIP assay using differentiated TH17 cells revealed that Etv5 bound at several sites 
across the Il17a-Il17f locus, including the promoters and several conserved noncoding 
sequences (Fig 8, A and B). Jurkat T cells transfected with IL17A and IL17F luciferase 
reporters and a plasmid encoding Etv5 demonstrated that Etv5 promotes the transcriptional 
activity of the IL17A and IL17F promoters but not a nuclear factor of activated T cells 
promoter, in a dose-dependent manner (Fig 8, C). To define the modifications of histones 
correlated with active (H3K4 trimethylation and H3K27 acetylation) and repressed (H3K27 
trimethylation) gene expression at the Il17a-Il17f locus, we performed ChIP assays from 
control and Etv5-deficient TH17 cells. We further observed decreased H3K4 methylation 
and H3K27 acetylation and increased H3K27 methylation across the Il17a-Il17f locus in the 
absence of Etv5 (Fig 8, D). In addition, the association of histone acetyltransferase p300 was 
decreased at the Il17a-Il17f locus in Etv5-deficient TH17 cells compared with that seen in 
control cells (Fig 8, D). These results suggested that Etv5 directly promotes IL-17 
production, recruits histone-modifying enzyme, and mediates epigenetic changes at the 
Il17a–Il17f locus in TH17 cells.
DISCUSSION
The development of specialized helper T-cell subsets requires a network of transcription 
factors that promote the expression and production of specific cytokines. TH17 development 
requires the activity of STAT3-activating cytokines and the induction of STAT3 target 
genes, including Rorc, Batf, and Irf4, in TH17 cell differentiation. In this report we 
demonstrate that Etv5 is downstream of STAT3 in directly promoting Il17a/f expression and 
mediating changes in histone modifications at the Il17a/f locus. In the HDM-induced 
allergic airway inflammation model, Etv5 mutant mice had reduced lung inflammation, 
mucus production in the airway, and IL-17 production compared with control mice.
The requirement for IL-17 in asthma is not completely defined. Increased IL-17A and 
IL-17F levels are associated with severe asthma in patients.37 IL-17 produced from activated 
CD4+ T cells induces the expression of macrophage- and neutrophil-attracting chemokines 
that recruit inflammatory cells into the airways.38 However, in mouse models IL-17 has 
differential effects during sensitization or challenge, and the requirement for IL-17 varies 
among model systems.32,39–42 Importantly, the HDM adjuvant–free model is dependent on 
IL-17 in addition to TH2 cytokines.30–33 IL-17 production and neutrophil recruitment in the 
lung are increased after HDM sensitization and challenge.43 We observed a significant 
decrease in IL-17 production in the lung, BAL fluid, and peripheral lymphoid organs, as 
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well as diminished neutrophil-attracting chemokine levels and neutrophil recruitment to the 
lung in Etv5 mutant mice compared with that seen in control mice. Although Cxcl1 and 
Cxcl2 are IL-17– inducible genes, only the latter was affected when IL-17 levels were 
reduced in Etv5-mutant mice or blocked with anti–IL-17A antibody. The result suggested 
Cxcl2 expression was regulated differentially compared with Cxcl1 in this model. Indeed, in 
a model of sterile inflammation, IL-17 controls neutrophil trafficking by preferentially 
regulating the expression of Cxcl2 but not Cxcl1.44 In addition, it has been demonstrated 
that Cxcl1 expression is associated with systemic inflammation and that Cxcl2 expression is 
limited to localized inflamed tissue.45
Although HDM sensitization and challenge elicits TH2 responses,30,31,43 our data 
demonstrated that IL-17 was the most abundant cytokine produced in the lung, suggesting 
IL-17 production from T cells is critical for inflammation in this model. In the absence of 
Etv5 in T cells, there is diminished inflammation and reduced IL-17 concentrations, without 
any corresponding effects on the amounts of TH2 cytokine production. In addition to 
decreased neutrophil recruitment to the lung, eosinophil numbers were also reduced. 
Because IL-17A and IL-17F are shown to have differential effects on eosinophil recruitment 
during antigen-induced airway inflammation,41 further studies are needed to determine 
whether IL-17 is responsible for the reduction in eosinophil numbers in the lung in this 
model. Importantly, we demonstrate that blocking IL-17A in the HDM model decreases 
cellular infiltrates similarly to that observed in mice lacking Etv5 in T cells. Moreover, 
intranasal administration of IL-17A/F to HDM-challenged Etv5 mutant mice results in a 
recovery of inflammation in the lung. Our results suggest that TH17 production of IL-17 
provides a unique contribution to the inflammatory milieu in the development of allergic 
pulmonary inflammation.
Our data show that Etv5 deficiency in T cells does not alter expression of TH17 transcription 
factors or other TH17 cytokines, suggesting a restricted effect on expression of the Il17a-
Il17f locus. This is unique among transcription factors that promote TH17 development, 
including retinoic acid–related orphan receptor γt, interferon regulatory factor 4, and B-cell 
activating transcription factor-like, which regulate multiple components of the TH17 genetic 
program.12,13,15,16,46 It is also important to note that Etv5 has a critical role in TH17 
cytokine production despite expression of Etv5 not being specific for TH17 cells. This 
highlights that the amount of expression of a transcription factor is not always the most 
important determinant of function. Our results further document that transcription factors 
that are not restricted to a particular subset still play obligate roles in defining cellular 
phenotype in cooperation with lineage-specific factors.
These results demonstrate that Etv5 is a novel STAT3-induced transcription factor that 
directs expression of the Il17a-Il17f locus in TH17 cells. This is consistent with a recent 
report that Etv5 also contributes to IL-17 production in γδ T cells and suggests that Etv5 
might have common functions among multiple IL-17– secreting T-cell populations.47 Our 
results further suggest that in addition to lineage regulators, such as Rorc, Irf4, and Batf, 
which regulate multiple genes in a subset, there are additional transcription factors that are 
part of the helper T-cell subset differentiation program that have a more restricted and 
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specific function. Thus Etv5 represents a unique contributing factor that positively regulates 
inflammatory responses in TH17 cells and promotes allergic airway inflammation.
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Refer to Web version on PubMed Central for supplementary material.
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Key messages
• Etv5 directly promotes IL-17 production in TH17 cells.
• Mice that lack Etv5 in T cells display decreased airway inflammation compared 
with that seen in wild-type mice.
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FIG 1. 
Characterization of mice with Efv5-deficient T cells. A, Naive CD4+CD62+ T cells from 
control and Etv5fl/fl CD4-Cre+ mice were activated with anti-CD3 and anti-CD28 for 5 days. 
Nuclear lysates were extracted and immunoblotted for Etv5 and β-actin as a control. B and 
C, Total cells were isolated from the thymus, spleen, and lymph nodes of control and Etv5 
mutant mice and stained for cell-surface markers, with the percentage of positive cells (Fig 
1, B) and cell numbers (Fig 1, C) shown. Data are representative of 2 independent 
experiments with similar results (Fig 1, A and B) or are means ± SEMs of 3 mice per group 
and representative of 2 independent experiments with similar results (Fig 1, C).
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FIG 2. 
Helper T-cell differentiation in the absence of Etv5 in T cells. Naive control and Etv5-
deficient CD4+CD62L+ T cells were activated (TH0) or cultured under TH1, TH2, TH17, and 
Treg cell polarizing conditions. Etv5 expression was measured in helper T-cell subsets by 
using qRT-PCR before and after 6 hours of anti-CD3 stimulation (A), immunoblotting (B), 
or intracellular staining (C) before anti-CD3 stimulation. Δ Mean fluorescence intensity was 
calculated by subtracting the background from the signal of Etv5 antibody. TH1, TH2, and 
TH17 cells were used for assessing cytokine production by means of ELISA after 24 hours 
of anti-CD3 stimulation (D) and gene expression analysis after (Ifng, Il4, and Il17a; E) or 
before (Tbx21, Gata3, and Rorc; F) 6 hours of anti-CD3 stimulation by means of qRT-PCR. 
Data are means ± SEMs of 4 independent experiments (Fig 2, D-F) or means ± SDs of 
replicate samples (Fig 2, A) and representative of 3 independent experiments with similar 
results (Fig 2, A-C). *P < .05. NS, Not significant.
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FIG 3. 
Etv5 mutant mice have reduced HDM-induced allergic airway inflammation. A, Wild-type 
mice were immunized (intranasally [i.n.]) with HDM for 5 weeks to induced allergic 
inflammation and treated with anti–IL-17A or IgG1 antibodies (intraperitoneally [i.p.]). B, 
Total and inflammatory cell counts in the lungs and BAL fluid of HDM-induced airway 
inflammation in wild-type mice. C, Total cells from lungs of wild-type mice were used for 
gene expression analysis by means of qRT-PCR. D-G, Control and Etv5 mutant mice were 
sensitized and challenged (intranasally) with HDM for 5 weeks to induce allergic 
Pham et al. Page 17
J Allergy Clin Immunol. Author manuscript; available in PMC 2015 July 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
inflammation. Inflammatory cells in the lung tissue and BAL fluid of control and Etv5 
mutant mice were as follows: DC, dendritic cells; Eos, eosinophils; Lymph, lymphocytes; 
Mac, macrophages; Neu, neutrophils. Fig 3, F, Cell infiltration in the lungs and mucus in the 
airways of control and Etv5 mutant mice were evaluated by means of hematoxylin and eosin 
(H&E) and periodic acid–Schiff (PAS) staining. Fig 3, G, Total cells from lungs of control 
and Etv5 mutant mice were used for gene expression analysis by means of qRT-PCR. Data 
are means ± SEMs of 5 to 6 mice per group (Fig 3, A-G) and representative of 2 
independent experiments with similar results. *P < .05. NS, Not significant.
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FIG 4. 
Etv5 regulates TH17 cells in HDM-induced allergic airway inflammation. A-C, Lung and 
BAL cells from HDM-induced allergic airway inflammation in control and Etv5 mutant 
mice (from Fig 3) were stimulated with PMA and ionomycin for 6 hours to assess cytokine 
production (Fig 4, A-C) by using intracellular staining, with the average percentage of 
positive cells (Fig 4, B) and cell numbers (Fig 4, C) shown. D and E, Cells from mediastinal 
lymph nodes (MLN) were stimulated with HDM for 5 days. BAL fluid (Fig 4, D) and cell-
free supernatant (Fig 4, E) were used to assess cytokine production by using ELISA. Data 
are means ± SEMs of 6 mice per group and representative of 2 independent experiments 
with similar results. *P < .05.
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FIG 5. 
IL-17 cytokine contributes to HDM-induced allergic airway inflammation. Control and Etv5 
mutant mice were immunized (intranasally [i.n.]) with HDM for 5 weeks to induce allergic 
inflammation. A, Mice were treated with IL-17A/F cytokine or PBS on weeks 3, 4, and 5. B, 
Total and inflammatory cells (eosinophils and neutrophils) in the lung tissue and BAL fluid 
of control and Etv5 mutant mice. C, Total cells from lungs of control and Etv5 mutant mice 
were used for gene expression analysis by means of qRT-PCR. Data are means ± SEMs of 5 
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mice per group and representative of 2 independent experiments with similar results. *P < .
05.
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FIG 6. 
Efv5 is regulated by STAT3-activating cytokines in TH17 cells. Naive wild-type 
CD4+CD62L+ T cells were cultured under TH17-polarizing conditions. A, Kinetics of Etv5 
gene expression during TH17 cell differentiation. B and C, TH17 cells were stimulated with 
IL-6, IL-23, and IL-12 for 2 hours before gene expression analysis by means of qRT-PCR 
(Fig 6, B) or protein expression by means of intracellular staining (Fig 6, C). D, Naive 
control and Sfaf3-deficient CD4+ T cells were activated with anti-CD3 and anti-CD28 in the 
presence or absence of IL-6 for 48 hours, rested overnight, and restimulated with IL-6, 
IL-12, or IL-23 for 2 hours before gene expression analysis by using qRT-PCR. E, 
Schematic of Etv5 promoter-containing STAT3-binding sites. F, Cells prepared as in Fig 6, 
B, were used for ChIP analysis with STAT3 antibody and IgG as a control. Data are means 
± SDs of replicate samples and representative of 3 independent experiments with similar 
results (Fig 6, A-F). *P < .05.
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FIG 7. 
Etv5 promotes cytokine production in TH17 cells. A-C, Naive CD4+CD62L+ T cells were 
isolated from wild-type mice and differentiated under neutral conditions (TH0) or TH17 
culture conditions. On day 2, cells were transduced with either control or Etv5-YFP (Etv5)–
expressing retrovirus. On day 5, TH17 cells were stimulated with PMA and ionomycin for 6 
hours before intracellular staining for cytokine production (Fig 7, A), with the percentage 
positive cells shown in Fig 7, B. Data are gated on YFP+cells. Fig 7, C, Cytokine production 
from sorted YFP+ TH0 cells was assessed by using ELISA after 24 hours of stimulation with 
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anti-CD3. D and F, Wild-type TH17 cells were transfected with control or siRNA-specific 
Etv5, rested overnight, and restimulated with anti-CD3 to assess cytokine production by 
means of ELISA (Fig 7, D) and gene expression by using qRT-PCR (Fig 7, F). E and G, 
Control and Etv5-deficient TH17 cells were restimulated with anti-CD3 to assess cytokine 
production by using ELISA (Fig 7, E) and gene expression by using qRT-PCR (Fig 7, G). 
Data are means ± SEMs of 4 independent experiments. *P < .05 and **P < .01. NS, Not 
significant.
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FIG 8. 
Etv5 binds the Il17a-Il17f locus in TH17 cells. A, Schematic of the Il17a-Il17f locus 
containing ETS-binding sites. B and D, Naive CD4+CD62L+ T cells were isolated from 
control and Etv5 mutant mice and differentiated under TH17 culture conditions. ChIP 
analyses were performed by using differentiated control TH17 cells to examine transcription 
factor binding (Fig 8, B) or differentiated control and Etv5-deficient TH17 cells to assess 
histone modification and the association of histone-modifying enzyme (Fig 8, D) at the 
Il17a–Il17f locus. C, Luciferase activity in Jurkat T cells transfected with increased 
concentrations of plasmid encoding Etv5 along with IL17A, IL17F, or NFAT luciferase 
reporters and then activated for 6 hours with PMA and ionomycin. Data were normalized to 
control samples. Data are means ± SDs of replicate samples and representative of 3 to 4 
independent experiments with similar results. RU, Relative unit.
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